Anti-interleukin-5 therapy in severe asthma}, Source: Eur Respir Rev 2013; 22: 251-257 Year: 2013
Chronic hypoventilation and its management}, Source: Eur Respir Rev 2013; 22: 325-332 Year: 2013
Severe asthma: classification and treatment Source: Virtual Congress 2021 – Clinical year in review Year: 2021
Chronic post-embolic pulmonary hypertension: a new target for medical therapies?}, Source: Eur Respir Rev 2013; 22: 258-264 Year: 2013
Treatment of severe childhood asthma: what’s the evidence? Source: Annual Congress 2005 - Difficult asthma in children Year: 2005
Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
Severe asthma: approach to diagnosis and treatment Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008
Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019
Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future}, Source: Eur Respir Rev 2013; 22: 281-291 Year: 2013
Severe asthma (SA) compared to non severe persistent asthma (PA) in children: An Italian on-line database Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014
Sleep disorders in COPD: the forgotten dimension}, Source: Eur Respir Rev 2013; 22: 365-375 Year: 2013
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016
Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015
LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016
Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013
Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype? Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016
Severe asthma guidelines: 2019 update Source: Virtual Congress 2020 – German programme 2020 Year: 2020
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016